Needham & Company - Investment Banking - Corporate Finance - Team - Industry

Healthcare

Charles Baltic
Managing Director

Telephone: (212) 705-0496
Email: cbaltic@needhamco.com

Charles Baltic joined Needham & Company in March 2009. Charles is the Co-Head of the Investment Banking Healthcare Group. He has over 15 years of experience working with life sciences and healthcare companies in a significant variety of transactional contexts. His transactional experience spans a broad range of equity, convertible and debt financings in the public and private markets, as well as numerous M&A and advisory assignments, for both public and private companies. During that time he has been involved in raising over $5 billion in life sciences financings. Prior to joining Needham, Charles most recently headed the biotechnology practice at CRT Capital Group from 2006 to 2009. From 2001 to 2006, he served as a managing director in Healthcare Investment Banking at Wachovia Securities where he headed Wachovia’s biotechnology practice. Prior to Wachovia, he was with Healthcare Investment Banking at Cowen and Company for six years, ultimately serving as a director in life sciences. Prior to beginning his investment banking career in 1996, Charles practiced corporate and securities law with Dewey Ballantine, representing numerous healthcare and securities clients. He holds BA and JD degrees from Georgetown University and an MBA degree in finance from the Wharton School of the University of Pennsylvania. He is also a founding Trustee and Chairs the Development Committee of the non-profit Hope Funds for Cancer Research.

Laura Black
Managing Director

Telephone: (650) 561-1241
Email: lblack@needhamco.com

Laura Black joined Needham & Company in 1999. Laura has over 20 years experience in high-technology, business strategy and finance. At Needham, she has served as a senior banker on over $5 billion of public financings and M&A advisories, including several transactions in the IT infrastructure market. She previously served as head of corporate finance at Black & Company, where she raised over $500 million of public equity capital for Pacific Northwest companies and completed numerous M&A and strategic advisory assignments. Laura previously served as director of M&A for TRW Avionics & Surveillance Group (ASG), where she evaluated acquisition candidates, managed direct investments and divestitures, and raised venture capital to back spin-off companies. She began her career at TRW as a hardware and systems design engineer. She earned an MS in Management from the Stanford University Graduate School of Business and also holds an MSEE from Santa Clara University and a BSEE from the University of California at Davis.

Simon Gill
Managing Director

Telephone: (212) 705-0378
Email: sgill@needhamco.com

Simon Gill rejoined Needham & Company in January 2010 as Co-Head of the Investment Banking Healthcare Group, having been a senior biotechnology banker at the firm in 2003 - 2006. He has 27 years of investment banking experience, working primarily with U.S. and Canadian biotechnology and healthcare companies. He has been involved in over 250 transactions in his career, and in the last six years has completed over 40 financing and M&A transactions for biotechnology companies. Prior to rejoining Needham, Simon was Co Head of U.S. Healthcare Investment Banking at RBC Capital Markets. He began his career with Credit Suisse First Boston in London in 1982. He has worked in the U.S. since 1984, mainly focused on providing financial advisory and capital raising services for U.S. healthcare companies. In addition to RBC and CSFB, he has worked at SBC Warburg (now called UBS) and Prudential Securities, where he was Head of Investment Banking. Simon graduated from the University of Oxford in 1982 with MA and BA degrees.

Designed and Developed by Piehead Productions LLC.